SLC5A2 and acute kidney injury: Despite robust data on nephroprotective effects of long-term treatment with SGLT2 inhibitors, there are concerns that such therapy may lead to acute kidney injury due to reduced plasma volume, an early decline in glomerular pressure and GFR via tubulo-glomerular feedback activation, and hypoxia in the renal medulla [21–23].